Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-γ

被引:117
作者
Arici, M
Chana, R
Lewington, A
Brown, J
Brunskill, NJ
机构
[1] Univ Leicester, Dept Cell Physiol & Pharmacol, Fac Med & Biol Sci, Leicester LE1 9HN, Leics, England
[2] Univ Leicester, Dept Nephrol, Fac Med & Biol Sci, Leicester LE1 9HN, Leics, England
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷 / 01期
关键词
D O I
10.1097/01.ASN.0000042167.66685.EA
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
In nephrotic syndrome, large quantities of albumin enter the kidney tubule. This albumin carries with it a heavy load of fatty acids to which the proximal tubule cells are exposed at high concentration. It is postulated that exposure to fatty acids in this way is injurious to proximal tubule cells. This study has examined the ability of fatty acids to interact with peroxisome proliferator-activated receptors (PPAR) in primary cultures of human proximal tubule cells. Luciferase reporter assays in transiently transfected human proximal tubule cells were used to show that albumin bound fatty acids and other agonists activate PPARgamma in a dose-dependent manner. One of the consequences of this activation is apoptosis of the cells as determined by changes in cell morphology, evidence of PARP cleavage, and appearance of DNA laddering. Overexpression of PPARgamma in these cells also results in enhanced apoptosis. Both fatty acid-induced PPAR activation and apoptosis in these cells can be blocked by PPAR response element decoy oligonucleotides. Activation of PPARgamma by the specific agonist PGJ(2) is associated with inhibition of cell proliferation, whereas activation by albumin bound fatty acids is accompanied by increased proliferation. However, the net balance of apoptosis/proliferation favors deletion of cells. These results implicate albumin-bound fatty acids as important mediators of tubular injury in nephrosis and provide fresh impetus for pursuit of lipid-lowering strategies in proteinuric renal disease. njb18@le.ac.uk.
引用
收藏
页码:17 / 27
页数:11
相关论文
共 53 条
[1]
Activators of peroxisome proliferator-activated receptor γ have depot-specific effects on human preadipocyte differentiation [J].
Adams, M ;
Montague, CT ;
Prins, JB ;
Holder, JC ;
Smith, SA ;
Sanders, L ;
Digby, JE ;
Sewter, CP ;
Lazar, MA ;
Chatterjee, VKK ;
O'Rahilly, S .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) :3149-3153
[2]
ALTOIK S, 1997, GENE DEV, V11, P1987
[3]
Peroxisome proliferator-activated receptor γ1 (PPARγ1) expresses in rat mesangial cells and PPARγ agonists modulate its differentiation [J].
Asano, T ;
Wakisaka, M ;
Yoshinari, M ;
Iino, K ;
Sonoki, K ;
Iwase, M ;
Fujishima, M .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2000, 1497 (01) :148-154
[4]
Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans - No alteration in adipose tissue of obese and NIDDM patients [J].
Auboeuf, D ;
Rieusset, J ;
Fajas, L ;
Vallier, P ;
Frering, V ;
Riou, JP ;
Staels, P ;
Auwerx, J ;
Laville, M ;
Vidal, H .
DIABETES, 1997, 46 (08) :1319-1327
[5]
Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Δ12,14-prostaglandin J2 [J].
Bishop-Bailey, D ;
Hla, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (24) :17042-17048
[6]
Receptor-mediated endocytosis of albumin by kidney proximal tubule cells is regulated by phosphatidylinositide 3-kinase [J].
Brunskill, NJ ;
Stuart, S ;
Tobin, AB ;
Walls, J ;
Nahorski, S .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (10) :2140-2150
[7]
Fibronectin production by human tubular cells: The effect of apical protein [J].
Burton, CJ ;
Combe, C ;
Walls, J ;
Harris, KPG .
KIDNEY INTERNATIONAL, 1996, 50 (03) :760-767
[8]
CAMERON JS, 1978, CLIN NEPHROL, V10, P213
[9]
CAMERON JS, 1990, AM J NEPHROL, V10, P81
[10]
Differential activation of peroxisome proliferator-activated receptor-γ by troglitazone and rosiglitazone [J].
Camp, HS ;
Li, O ;
Wise, SC ;
Hong, YH ;
Frankowski, CL ;
Shen, XQ ;
Vanbogelen, R ;
Leff, T .
DIABETES, 2000, 49 (04) :539-547